Evidence map›Paper›PMID 22293177›Full record

ArticleThe Journal of clinical investigation2012

p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.

Murielle P Serres, Uta Kossatz, Yong Chi, James M Roberts, Nisar P Malek, Arnaud Besson

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. p27Histology and histopathology · 2025
    Pooled it
  2. Review
  3. p27Cells · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. p27Cells · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Regulation of p27Biomolecules · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Murielle P SerresINSERM UMR1037, Cancer Research Center of Toulouse, Toulouse, France.
Uta Kossatz
Yong Chi
James M Roberts
Nisar P Malek
Arnaud Besson
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACentre de Recherche en Cancérologie de Toulouse · FRFred Hutch Cancer Center · USUniversité de Toulouse · FR

Funding

CELL CYCLE REGULATION IN NORMAL AND CANCER CELLSR01CA118043 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROBERTS, JAMES M · 2006 to 2010
$2.4M
NCI NIH HHS 1R01CA118043NCI NIH HHS R01 CA118043
6 · The paper itself

Abstract

p27(Kip1) (p27) acts as a tumor suppressor by inhibiting cyclin-cyclin-dependent kinase (cyclin-CDK) activity. However, mice expressing a form of p27 that is unable to bind or inhibit cyclin-CDK complexes (p27(CK-)) have increased incidence of tumor development as compared with wild-type and p27(-/-) mice, revealing an oncogenic role for p27. Here, we identified a phenotype of multinucleation and polyploidy in p27(CK-) mice not present in p27(-/-) animals, suggesting a role for p27 in G2/M that is independent of cyclin-CDK regulation. Further analysis revealed that p27(CK-) expression caused a cytokinesis and abscission defect in mouse embryonic fibroblasts. We identified the Rho effector citron kinase (citron-K) as a p27-interacting protein in vitro and in vivo and found that p27 and citron-K colocalized at the contractile ring and mid-body during telophase and cytokinesis. Moreover, overexpression of the minimal p27-binding domain of citron-K was sufficient to rescue the phenotype caused by p27(CK-). Conversely, expression of a mutant p27(CK-) unable to bind citron-K did not induce multinucleation. Finally, by binding to citron-K, p27 prevented the interaction of citron-K with its activator RhoA. Taken together, these data suggest a role for p27 during cytokinesis via the regulation of citron-K activity.

Indexed as

AnimalsCyclin-Dependent Kinase Inhibitor p27CytokinesisEnzyme ActivationFibroblastsGenotypeHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMiceMice, TransgenicMitosisModels, BiologicalPolyploidyProtein Serine-Threonine KinasesrhoA GTP-Binding Proteincitron-kinaseCyclin-Dependent Kinase Inhibitor p27Intracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesrhoA GTP-Binding Protein

Identifiers

PMID22293177
PMCPMC3287231
OpenAlexW2142139892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.